People Briefs: CryoLife, VisionCare, Nihon Kohden, Nephros
This article was originally published in The Gray Sheet
CryoLife Executive Chairman retires. VisionCare Ophthalmic Technologies and Nihon Kohden, appoint new CEOs; Nephros appoints new leadership.
You may also be interested in...
FDA approved VisionCare Ophthalmic Technologies’ Implantable Miniature Telescope to treat macular degeneration in 65- to 74-year-old patients, expanding on the original 75-and-older indication and growing the potential market by about a third.
New CEOs at Nephros and Crescent Diagnostics, plus a new name and CEO for transcatheter valve accessory company. More people briefs.
The US FDA has overhauled its ‘Purple Book’ to make it a searchable database of biologics information. The agency is also seeking input on next steps.